Pankomab

Pankomab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target tumor specific glycosylation of MUC1
Identifiers
ATC code None
ChemSpider none
Synonyms PankoMab-GEX, anti-TA-MUC1

PankoMab is a humanized monoclonal antibody recognizing the tumor-specific epitope of mucin-1 (TA-MUC1), enabling it to differentiate between tumor MUC1 and non-tumor MUC1 epitopes.[1] PankoMab is being developed by Glycotope GMBH [2] and is currently undergoing a phase II clinical trial for ovarian cancer [3]

References

  1. http://www.cancer.gov/drugdictionary?cdrid=687630
  2. https://www.glycotope.com/pipeline/pankomab-gex
  3. http://clinicaltrials.gov/ct2/show/NCT01899599


This article is issued from Wikipedia - version of the Thursday, November 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.